Trial Profile
The Real Life Topical Field Treatment of Actinic Keratosis Study. An Observational Study Focusing on Patient Reported Outcomes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2019
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary) ; Diclofenac; Fluorouracil; Imiquimod
- Indications Actinic keratosis
- Focus Therapeutic Use
- Acronyms RAPID-ACT
- Sponsors LEO Pharma
- 23 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Feb 2015 New trial record